tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

NRSN Stock Latest News

NeuroSense Therapeutics Reports Positive Phase 2b Study Results for ALS Treatment
Company AnnouncementsNeuroSense Therapeutics Reports Positive Phase 2b Study Results for ALS Treatment
13d ago
6K
NRSN
NeuroSense Therapeutics Reports Key Progress and Financials
PremiumCompany Announcements
NeuroSense Therapeutics Reports Key Progress and Financials
2M ago
NRSN
NeuroSense Regains Nasdaq Compliance, Strengthens Position for ALS Treatment
PremiumCompany Announcements
NeuroSense Regains Nasdaq Compliance, Strengthens Position for ALS Treatment
2M ago
6K
NRSN
NeuroSense regains Nasdaq compliance
PremiumThe Fly
NeuroSense regains Nasdaq compliance
2M ago
NRSN
NeuroSense files to sell 5.28M ordinary shares for holders
PremiumThe Fly
NeuroSense files to sell 5.28M ordinary shares for holders
2M ago
NRSN
NeuroSense Partners with Pharma Giant to Propel ALS Drug PrimeC
PremiumCompany AnnouncementsNeuroSense Partners with Pharma Giant to Propel ALS Drug PrimeC
2M ago
6K
NRSN
NeuroSense enters binding term sheet to advance PrimeC for ALS
Premium
The Fly
NeuroSense enters binding term sheet to advance PrimeC for ALS
2M ago
NRSN
NeuroSense Advances ALS Treatment with PrimeC, Boosts Financial Position
Premium
Company Announcements
NeuroSense Advances ALS Treatment with PrimeC, Boosts Financial Position
3M ago
6K
NRSN
NeuroSense reports first nine months EPS (48c) vs. (55c) last year
PremiumThe Fly
NeuroSense reports first nine months EPS (48c) vs. (55c) last year
3M ago
NRSN
NeuroSense Therapeutics Regains Nasdaq Compliance
PremiumCompany Announcements
NeuroSense Therapeutics Regains Nasdaq Compliance
3M ago
6K
NRSN
NeuroSense cut to Hold at Maxim following PrimeC FDA feedback
PremiumThe Fly
NeuroSense cut to Hold at Maxim following PrimeC FDA feedback
3M ago
NRSN
NeuroSense downgraded to Hold from Buy at Maxim
PremiumThe Fly
NeuroSense downgraded to Hold from Buy at Maxim
3M ago
NRSN
NeuroSense Receives FDA Approval for Phase 3 Study of ALS Treatment
PremiumCompany AnnouncementsNeuroSense Receives FDA Approval for Phase 3 Study of ALS Treatment
3M ago
6K
NRSN
NeuroSense concludes Type C meeting with FDA for PrimeC treatment
Premium
The Fly
NeuroSense concludes Type C meeting with FDA for PrimeC treatment
3M ago
NRSN
NeuroSense files to sell 6.6M ordinary shares for holders
Premium
The Fly
NeuroSense files to sell 6.6M ordinary shares for holders
3M ago
NRSN
NeuroSense’s PrimeC Shows Promise in ALS Treatment
PremiumCompany Announcements
NeuroSense’s PrimeC Shows Promise in ALS Treatment
3M ago
6K
NRSN
NeuroSense announces ‘positive’ results from the PARADIGM study
PremiumThe Fly
NeuroSense announces ‘positive’ results from the PARADIGM study
3M ago
NRSN
NeuroSense Therapeutics Announces Securities Purchase Agreement
PremiumCompany Announcements
NeuroSense Therapeutics Announces Securities Purchase Agreement
3M ago
6K
NRSN
NeuroSense Therapeutics Secures Continued Nasdaq Listing
PremiumCompany Announcements
NeuroSense Therapeutics Secures Continued Nasdaq Listing
4M ago
6K
NRSN
Neurosense Therapeutics Secures $30 Million Equity Deal
PremiumCompany AnnouncementsNeurosense Therapeutics Secures $30 Million Equity Deal
4M ago
6K
NRSN
NeuroSense Completes Key ALS Trial Phase
Premium
Company Announcements
NeuroSense Completes Key ALS Trial Phase
4M ago
6K
NRSN
NeuroSense Therapeutics Advances ALS Drug Development Plans
Premium
Company Announcements
NeuroSense Therapeutics Advances ALS Drug Development Plans
4M ago
6K
NRSN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >